Teleflex Incorporated

Teleflex Launches ACCESS-MANTA Registry to Evaluate MANTA Vascular Closure Device

WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced the first patient enrollment in the ACCESS-MANTAâ„¢ Registry. This international, multicenter, prospective, observational, single-arm …

Teleflex Launches ACCESS-MANTA Registry to Evaluate MANTA Vascular Closure Device Read More

Teleflex Incorporated

New Study Reinforces UroLiftâ„¢ System as Gold Standard Treatment for Enlarged Prostate

WAYNE, PA — A groundbreaking study published in the Nature journal Prostate Cancer and Prostatic Diseases has bolstered the position of the UroLiftâ„¢ System as the leading minimally invasive surgical …

New Study Reinforces UroLiftâ„¢ System as Gold Standard Treatment for Enlarged Prostate Read More
Cornelis Networks

Cornelis Networks Introduces High-performance CN5000 Omni-Path Interconnect Family for AI and HPC environments

WAYNE, PA — Cornelis Networks, a front-runner in the provision of intelligent, high-performance networking solutions, has unveiled the Cornelisâ„¢ CN5000 Omni-Pathâ„¢. This high-performance interconnect product family is specifically designed to …

Cornelis Networks Introduces High-performance CN5000 Omni-Path Interconnect Family for AI and HPC environments Read More

Neuronetics, Inc

Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management

MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) announced this week significant updates to its proprietary NeuroStar software and TrakStar® Patient Data Management System. These enhancements aim to revolutionize patient care …

Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management Read More
Aclaris Therapeutics

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced disappointing top-line results from a Phase 2b study of zunsemetinib (ATI-450) in patients with moderate to severe rheumatoid arthritis …

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint Read More


Annovis Bio

Annovis Bio’s Buntanetap Demonstrates Potential to Lower Key Biomarkers in Parkinson’s Disease

BERWYN, PA — In a recent breakthrough, Annovis Bio (NYSE: ANVS), a biopharmaceutical company, has successfully performed measurements of critical biomarkers in the plasma of Parkinson’s disease patients. Utilizing buntanetap, …

Annovis Bio’s Buntanetap Demonstrates Potential to Lower Key Biomarkers in Parkinson’s Disease Read More
Virpax Pharmaceuticals

Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management

BERYWN, PA — In a significant move that promises to reshape the future of pain management, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced its intent to submit an Investigational New …

Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management Read More